Longo Umile Giuseppe, Papalia Rocco, De Salvatore Sergio, Marinozzi Andrea, Piergentili Ilaria, Lalli Alberto, Bandini Benedetta, Franceschetti Edoardo, Denaro Vincenzo
Research Unit of Orthopaedic and Trauma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Roma, Italy.
Research Unit of Orthopaedic and Trauma Surgery, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Roma, Italy.
J Clin Med. 2023 Feb 15;12(4):1540. doi: 10.3390/jcm12041540.
Insufficiently treated shoulder pain may cause mental disturbances, including depression and anxiety. The Hospital Anxiety and Depression Scale (HADS) is a patient-reported outcome measure (PROM) that aims to identify depression and anxiety in patients in nonpsychiatric wards. The aim of this study was to identify the minimum clinically important difference (MCID) and patient acceptable symptom state (PASS) scores for the HADS in a cohort of individuals with rotator cuff disease. Using the HADS, participants' degrees of anxiety and depression were assessed at inception and at their final assessment 6 months after surgery. To calculate the MCID and the PASS, distribution and anchor approaches were employed. The MCID from inception to final assessment was 5.7 on the HADS, 3.8 on the HADS-A, and 3.3 on the HADS-D. A 5.7 amelioration on the HADS score, 3.8 on the HADS-A, and 3.3 on the HADS-D, from inception to final assessment, meant that patients had reached a clinically meaningful improvement in their symptom state. The PASS was 7 on the HADS, 3.5 on the HADS-A, and 3.5 on the HADS-D; therefore, for the majority of patients, a score of at least 7 on the HADS, 3.5 on the HADS-A, and 3.5 on the HADS-D at final evaluation was considered a satisfactory symptom state.
肩部疼痛治疗不充分可能会导致精神障碍，包括抑郁和焦虑。医院焦虑抑郁量表（HADS）是一种患者报告结局指标（PROM），旨在识别非精神科病房患者的抑郁和焦虑情况。本研究的目的是确定肩袖疾病患者队列中HADS的最小临床重要差异（MCID）和患者可接受症状状态（PASS）评分。使用HADS，在入组时以及术后6个月的最终评估时对参与者的焦虑和抑郁程度进行评估。为了计算MCID和PASS，采用了分布法和锚定法。从入组到最终评估，HADS的MCID为5.7，HADS-A为3.8，HADS-D为3.3。从入组到最终评估，HADS评分改善5.7、HADS-A改善3.8、HADS-D改善3.3，意味着患者的症状状态在临床上有了有意义的改善。PASS在HADS上为7，在HADS-A上为3.5，在HADS-D上为3.5；因此，对于大多数患者来说，最终评估时HADS至少得7分、HADS-A至少得3.5分、HADS-D至少得3.5分被认为是令人满意的症状状态。
